Rating History for InVivo Therapeutics (NVIV) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for NVIV
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/31/2017 N/A Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 2.45
(0.32)		 -86.94% Details